Search

everythinglearnresearchcommunity

for

Search:↓

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Cimetidine did not reduce hair growth in women with hirsutism.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Injecting fillers in the temple can cause serious complications, but the damage can be treated if managed properly.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A new therapy for a skin blistering condition has not been developed yet.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

A woman with severe angioedema improved significantly after treatment with rituximab.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.